Back

News

Learn more about our company, latest developments in clinical diagnostics, and scientific breakthroughs in the rare disease field. Stay on top, subscribe to our newsletter and follow us on social media.

  1. News

News


CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 12. Mai 2021

  • CENTOGENE erweitert sein Test-Angebot am...

Providing patients with genetic testing designed to accelerate the diagnosis and personalized treatment of Parkinson’s...


CENTOGENE’s rare disease mutation database offers new features and previously unpublished variants


Research leads to diagnosis and treatment options for rare disease patients


Delivers very strong financial results in unprecedented year


CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, April 14, 2021 (GLOBE NEWSWIRE) – Centogene N.V. (Nasdaq: CNTG), a...


CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, April 8, 2021 (GLOBE NEWSWIRE) – Centogene N.V. (Nasdaq: CNTG), a...


CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, March 9, 2021 (GLOBE NEWSWIRE)

  • Rostock International Parkinson's...

ERLÄUTERUNG ZUR PRESSEMITTEILUNG: CENTOGENE ENTDECKT BEI DER SEQUENZIERUNG POSITIVER BEFUNDE SELTENE SARS-COV-2 VARIANTE...


CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 04. März 2021

  • Ab nächster Woche bis zu den Pfingstferien...